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Introduction
In primary healthcare, eye infections are a common presenting 
problem. ‘Red eye’, ‘conjunctivitis’ and ‘corneal  ulcer/keratitis’ 
were among the top five problems most commonly referred to 
ophthalmology departments.1
To ensure a good visual outcome for the patient, the medical 
practitioner should make a prompt diagnosis and start 
appropriate interventions. Conjunctivitis typically does not 
threaten vision, but infections of the cornea or inside the 
eye are serious threats and require immediate referral to an 
ophthalmologist.
Infectious conjunctivitis
Conjunctivitis is a common condition that causes dilation of the 
conjunctival blood vessels and resultant inflammation. 
Both viral and bacterial conjunctivitis (Figure 1) present with a 
red eye and are highly contagious and perhaps not in keeping 
with William Shakespeare’s infamous remark “Take thou some 
new infection to thy eye, and the rank poison of the old will die.”32
Assessment should include checking visual acuity and 
examination with a torch or slit lamp. Fluorescein drops should 
be instilled in the conjunctival sac and the eye viewed with the 
cobalt blue light of the slit lamp, or fundoscope, to rule out any 
signs of corneal ulceration or infection. A history of cold sores 
or shingles should be sought and the patient examined for cold 
sores or a vesicular rash in case the infection is due to herpes 
simplex or zoster virus.2
Viral conjunctivitis
Viral conjunctivitis is the most common cause of infectious 
conjunctivitis. This infection is more common in adults than in 
children. Around 65–90% of cases are caused by adenovirus. 
Occasionally, herpes simplex or zoster virus is responsible. Patients 
can generally be advised that viral conjunctivitis is self-limiting 
and, as there are no specific treatments, for comfort they can 
use cold compresses, artificial tears or topical antihistamines.2,3 
Antibiotics are not needed, are costly and may increase antibiotic 
resistance. If there is evidence of herpes simplex or zoster virus 
then antivirals should be prescribed, such as aciclovir ointment 
or ganciclovir gel.
When viral conjunctivitis is severe or the patient experiences 
symptoms after its resolution, the patient should be referred to 
an ophthalmologist. This is to consider topical steroids and to 
exclude an immune ‘post-viral’ keratitis.
Bacterial conjunctivitis
Although a less frequent cause of conjunctivitis, bacterial 
conjunctivitis is more common in children. The most common 
bacteria are Haemophilus influenza, Streptococcus pneumoniae 
and Staphylococcus aureus.4 
When compared to placebo, the use of antibiotic eye drops is 
associated with improved rates of clinical and microbiological 
remission.4 A broad-spectrum topical antibiotic is recommended. 
The medical practitioner can select  the most convenient or least 
expensive option, as there is no clinical evidence suggesting the 
superiority of any particular antibiotic.3,4
The initial treatment recommended by Therapeutic Guidelines: 
Antibiotic5:
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Abstract
It is known that not all red eyes are caused by infections. Furthermore, not all eye infections will react to antibiotic eye drops. Most 
cases of conjunctivitis are due to viral causes, do not require antibiotic eye drops and are usually self-limiting. Serious ophthalmic 
conditions such as infectious keratitis can lead to blindness; it is an emergency that requires specialist treatment. Also infectious 
endophthalmitis has become more frequent with the use of intravitreal injections. Intravitreal antibiotics are needed to try and 
prevent visual loss. To ensure therapeutic local exposure ophthalmic antibiotic solutions should be applied frequently into the eye.
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• Chloramphenicol 0.5% eye drops, one to two drops every two 
hours for the first 24 hours, decreasing  to six-hourly until the 
discharge resolves, for up to seven days
• Framycetin sulfate 0.5% eye drops, 1–2 drops every 1–2 hours 
for the first 24 hours, decreasing to eight-hourly until discharge 
resolves, for up to seven days.
It should be impressed on the patient that the frequency of eye 
drop installation should be adhered to as this will ensure and 
maintain a therapeutic concentration and therefore exposure to 
the antimicrobial in the eye. 
Chloramphenicol 1% eye ointment may be used at bedtime. 
Gentamicin, tobramycin and quinolone eye drops are not 
recommended for empiric treatment. If the condition does not 
improve within five days, the patient should be immediately 
referred to an ophthalmologist.
Figure 1: Conjunctivitis
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Neisseria gonorrhoeae causing conjunctivitis is relatively 
uncommon but should be considered in neonates and sexually 
active young adults. If suspected, the medical practitioner should 
take conjunctival swabs for Gram staining and special culture 
for Neisseria species.6 Patients should be referred immediately 
to an ophthalmologist. Antibiotic therapy is the recommended 
treatment and ceftriaxone is the drug of choice.3 Additionally, 
patients should lavage the infected eye with saline and add 
therapy to cover for Chlamydia.2
Chlamydial conjunctivitis
Most cases of Chlamydial conjunctivitis are unilateral and 
have concurrent genital infection. Symptoms usually include 
conjunctival hyperemia, mucopurulent discharge and lymphoid 
follicle formation.6 Patients with symptoms should be referred 
immediately to an ophthalmologist. Oral antibiotics, such as 
azithromycin or doxycycline, are effective treatments.7
Infectious keratitis
Infection of the cornea (or microbial keratitis) is an ophthalmic 
emergency requiring immediate attention as it can progress 
rapidly. It is a significant cause of corneal blindness8 and is one 
of the most common causes of visual impairment in working age 
adults.9 In the USA, nearly 30 000 cases of microbial keratitis are 
reported annually.10
If infectious keratitis is suspected, the medical practitioner should 
take a history to look for risk factors such as contact lenses, corneal 
abrasions, physical and chemical trauma, refractive surgery, 
diabetes, immunosuppressive diseases and topical steroids.10,11 
The type of infecting organism varies according to the climate 
and geographical region and the patient’s risk factors.
Bacterial keratitis
Bacterial infection is the most common cause of infectious 
keratitis. Common causal bacteria include S. aureus, coagulase-
negative staphylococci, S. pneumoniae and Pseudomonas 
aeruginosa.10,11 
P. aeruginosa is the most common microorganism implicated in 
bacterial keratitis among contact lens wearers. Less commonly, 
fungi or acanthamoeba can 
be responsible (Figure 2).12 
Fungi should be suspected 
when there is trauma 
particularly with vegetative 
matter and is more common 
in rural environments. 
Increase suspicion for 
acanthamoeba, if a patient 
has been swimming or in a 
spa while wearing contact 
lenses. 
Specific antifungal or anti-acanthamoebal therapy is needed 
and treatment may last some months and can include 
regimens of various topical preparations, e.g. Neomycin-
Polymyxin, B-Gramicidin, polyhexamethylene biguanide 
(PHMB), chlorhexadine, and voriconazole.  Some practitioners 
recommend oral ketoconazole.13-15 
The signs and symptoms of bacterial keratitis (Figure 3) can 
include pain, photophobia, blurred vision, corneal opacity or 
pus inside eye, or contact lens wearers with red eye or increasing 
pain. These should be referred promptly to an ophthalmologist 
for a slit lamp examination and corneal scraping.16
The mainstay of treatment is topical antibiotics and options 
include monotherapy with fluoroquinolones (ciprofloxacin 
0.3% or ofloxacin 0.3% 1–2 drops hourly for 48 hours, then 
every 4 hours until healed) or some authors prefer fortified 
aminoglycoside/cephalosporin combinations (fortified cefalotin 
Figure 2: Acanthamoeba Keratitis
Figure 3: Eye with non-ulcerative sterile keratitis
(https://commons.wikimedia.org/wiki/File:Clare-314.jpg)
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5% plus gentamicin 0.9% 1–2 drops hourly for 48 hours, then 
reduce frequency according to treatment response).5 These 
regimens have similar effectiveness but fluoroquinolones 
reduce the risk of chemical conjunctivitis and ocular discomfort. 
Compared to ofloxacin, ciprofloxacin increases the risk of white 
corneal precipitates.17 Occasionally, corneal grafting may be 
needed to eradicate the organism or repair damage. 
In primary healthcare, chloramphenicol is the most common 
first-line antibiotic prescribed for red eye. It is a bacteriostatic, 
broad-spectrum antibiotic but devoid of activity against 
P. aeruginosa.18 Therefore, primary healthcare providers should 
not prescribe chloramphenicol when microbial keratitis is 
suspected as this delays appropriate treatment, with the risk of 
the patient losing vision or the eye.18,19
Herpes simplex keratitis
Keratitis caused by herpes simplex virus is an important cause of 
infectious blindness in developed countries. The global incidence 
of herpes simplex keratitis was calculated at approximately 
1.5 million with 40 000 new cases of severe monocular visual 
impairment or blindness per year.20 Herpes simplex keratitis 
can be classified as epithelial, stromal, endothelial or mixed, 
depending on which layer of the cornea is involved. It may also 
be considered as primary or recurrent depending on whether it 
is the patient’s first episode. If suspected, the practitioner should 
ask about a history of cold sores or previous viral keratitis as 
this can be the first clue to the diagnosis. The clinical features 
of herpes simplex virus keratitis can be identified on slit lamp 
examination.21,22
Epithelial herpes simplex keratitis typically manifests as a 
dendritic ulcer. To visualise the ulcer, fluorescein staining and a 
cobalt blue light are needed (Figure 4) .21 Preferred treatment is 
aciclovir ointment five times daily for 14 days.23-25
Stromal herpes simplex 
keratitis presents with 
haze or opacity of the 
stroma, with or without 
ulceration, scarring or 
vascularisation. Endothelial 
keratitis is characterised by 
keratitic precipitates on the 
endothelium and corneal 
oedema.23 Management 
of stromal and endothelial 
keratitis involves referral to 
an ophthalmologist for oral antivirals (aciclovir or valaciclovir), 
topical steroids and follow-up until the episode has resolved.25
Infectious endophthalmitis
Endophthalmitis is an inflammation of the interior of the eye 
(Figure 5) and is also an ocular emergency, requiring urgent 
referral to an ophthalmologist to prevent permanent loss of 
vision. Endophthalmitis is an uncommon diagnosis but can 
have devastating visual outcomes. Endophthalmitis may be 
endogenous or exogenous. Exogenous endophthalmitis is 
caused by introduction of pathogens through mechanisms 
such as ocular surgery, open-globe trauma, and intravitreal 
injections. Endogenous endophthalmitis occurs as a result of 
hematogenous spread of bacteria or fungi into the eye.26
Infectious cause is the most common and various bacteria and 
fungi have been isolated as the cause of the endophthalmitis. 
The most common microorganisms involved are coagulase-
negative staphylococci, S. aureus, streptococci and Gram-
negative bacilli, Viruses: Herpes simplex , Fungi: Candida spp., 
Parasites: Toxoplasma gondii. A minor procedure is needed to 
obtain samples of vitreous and aqueous humour to isolate the 
organism. Other causes include penetrating trauma, allergic 
reaction, and retained intraocular foreign bodies.26
Urgent treatment is needed with intravitreal antibiotics such as 
ceftazidime or vancomycin injected by an ophthalmologist. In 
some cases vitrectomy may be beneficial to avoid loss of vision.5,27 
If there is a delay in administering intravitreal treatment, give 
single doses of:
• Oral ciprofloxacin 750 mg (child: 20 mg/kg up to 750 mg) plus 
intravenous vancomycin  (adult and child 15 mg/kg), or 
• Gentamicin (adult and child 5 mg/kg) intravenous plus 
intravenous cefazolin 2 g (child: 50 mg/kg up to 2 g).5
Adverse effects of topical antibiotics
Typically bacterial infections are treated with antibiotic drops of 
which some may cause systemic adverse effects. Underestimated 
is the fact that the volume of the drop produced by commercial 
dispensers (25–50 μL) exceeds the capacity of the conjunctival 
sac (10 μL), therefore a relative large volume of the liquid 
drains out of the eye. This liquid may be systemically absorbed 
through different pathways including conjunctiva, nose, lacrimal 
drainage, pharynx, gastrointestinal tract, aqueous humour, lids, 
cheeks and inner ocular tissues. However, the risk of systemic 
absorption is low since the corneal epithelium and conjunctival 
epithelium act as natural barriers limiting absorption of ocular 
drug resulting in a bioavailability of 5–10%.28 Some adverse 
effects can include skin irritation, itching or rash with sulfonamide, 
sulfacetamide and neomycin.28 Fluoroquinolones can cause local 





Conjunctival hyperemia with hypopyon in the anterior chamber
(https://jamanetwork.com/journals/jamaophthalmology/fullarticle/415216)
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irritation, stinging, chemosis, conjunctival hyperaemia, corneal 
precipitations and alteration of taste.29
A minimal dose and concentration of the antibiotic must be 
used in pregnancy to limit systemic absorption. Patients must 
be advised of punctual occlusion, nasolacrimal pressure and 
wiping extra liquid to prevent systemic absorption.30 Medical 
practitioners should always refer to the ABCD pregnancy category 
before prescribing antibiotics to pregnant women. Antibiotics 
such as chloramphenicol, tobramycin, fluoroquinolones and 
topical antivirals, e.g. aciclovir, are considered safe to use during 
pregnancy.31
Conclusion
Patients with eye infections typically present with pain, blurred 
vision and a red eye. Conjunctivitis is the most common eye 
infection to present to primary healthcare providers and rarely 
threatens vision. Corneal infection (keratitis) and endophthalmitis 
although less common pose a serious risk to vision. If the patient 
has a history of blurred vision, pain, photophobia, corneal 
opacity or hypopyon, specialist assessment is urgently called for.
Primary healthcare providers should avoid prescribing topical 
antibiotics for an eye infection unless the patient has bacterial 
conjunctivitis. Viral conjunctivitis is common and self-limiting. 
Urgent referral to an ophthalmologist for microbiological 
samples and treatment is needed for infectious keratitis and 
endophthalmitis. 
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